Eli Lilly Expands Compassionate Use Program for Next-Gen Obesity Treatment Retatrutide

By Elaine Chen · STAT News · 2026-08-04

According to reporting from STAT News, Eli Lilly is broadening the criteria for its experimental weight-loss therapy, retatrutide. The pharmaceutical giant plans to review new applications for early access after previously granting the drug to a single elderly patient under speci

According to reporting from STAT News, Eli Lilly is broadening the criteria for its experimental weight-loss therapy, retatrutide. The pharmaceutical giant plans to review new applications for early access after previously granting the drug to a single elderly patient under speci